SEC Form 4 · accession 0001179110-18-006388
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Hirschhorn
Officer — Executive VP, COO and CFO
Period of report
May 2, 2018
Accepted (ET)
May 7, 2018 · 5:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 2, 2018 | M | 3,558 | $22.30 | A | 32,111 | D | |
| Common StockF2,F3 | May 2, 2018 | S | 30,540 | $45.17 | D | 1,571 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $22.30 | May 2, 2018 | M | 3,558 | D | — | Mar 3, 2027 | Common Stock | 3,558 | 120,998 | D |
Explanation of responses
- F1The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on September 14, 2017.
- F3Represents the weighted average price of transactions ranging from $44.00 to $45.95. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.